<h4>Background</h4>Despite a consistent link between obesity and increased circulating levels of fibroblast growth factor-21 (FGF21), the effect of weight-loss interventions on FGF21 is not clear. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.